A survey of palivizumab for infants with cystic fibrosis in the UK.
McCormick
J
J
Southern
K W
KW
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents / Q000627:therapeutic use*; D015331:Cohort Studies; D003550:Cystic Fibrosis / Q000150:complications*; D019538:Health Care Surveys; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D000069455:Palivizumab; D018357:Respiratory Syncytial Virus Infections / Q000401:mortality / Q000517:prevention & control*; D006113:United Kingdom / Q000453:epidemiology
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000998:Antiviral Agents; D000069455:Palivizumab